Supplementary Tables S3-5 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

Supplementary Tables S3-5 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis

<p>Transcriptome analysis</p>

Salvato in:

Dettagli Bibliografici
Autore principale:	Nicole Dressel (16918215) (author)
Altri autori:	Loreen Natusch (16918218) (author), Clara M. Munz (16918221) (author), Santiago Costas Ramon (16918224) (author), Mina N.F. Morcos (16918227) (author), Anja Loff (16918230) (author), Björn Hiller (16918233) (author), Christa Haase (16918236) (author), Livia Schulze (16918239) (author), Patrick Müller (16918242) (author), Mathias Lesche (16918245) (author), Andreas Dahl (16918248) (author), Hella Luksch (16918251) (author), Angela Rösen-Wolff (16918254) (author), Axel Roers (16918257) (author), Rayk Behrendt (14932577) (author), Alexander Gerbaulet (16918260) (author)
Pubblicazione:	2025
Soggetti:	Cancer Molecular and Cellular Biology Immuno-oncology Hematological Cancers Immunology Innate immunity Tumor immunology animal models Stem Cell Biology Hematopoiesis
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Table S2 from Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis
di: Nicole Dressel (16918215)
Pubblicazione: (2025)

Supplementary file 1_Adopting orphan receptors: zebrafish Tlr4 homologs mediate responses to group IX/X transition metals.docx
di: Aaron P.D. Fox (22686512)
Pubblicazione: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
di: Yu Chen (1234761)
Pubblicazione: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
di: Yu Chen (1234761)
Pubblicazione: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
di: Yu Chen (1234761)
Pubblicazione: (2025)

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
di: Yu Chen (1234761)
Pubblicazione: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
di: Andrew O. Yam (15293045)
Pubblicazione: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
di: Andrew O. Yam (15293045)
Pubblicazione: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
di: Andrew O. Yam (15293045)
Pubblicazione: (2025)

Suppl video 4 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
di: Andrew O. Yam (15293045)
Pubblicazione: (2025)

Supplementary Table 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
di: Andrew O. Yam (15293045)
Pubblicazione: (2025)

Table 1_Integrative modeling of FOXO-mediated autophagy in NSCLC: linking cGAS–STING signaling to IL-6 dynamics.xlsx
di: Divya Rani (14414412)
Pubblicazione: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
di: Hansol Lee (15054787)
Pubblicazione: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
di: Hansol Lee (15054787)
Pubblicazione: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
di: Hansol Lee (15054787)
Pubblicazione: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
di: Hansol Lee (15054787)
Pubblicazione: (2025)

Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
di: Wei Hong (432102)
Pubblicazione: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
di: Ana Vujovic (15207479)
Pubblicazione: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
di: Jonathan M.J. Derry (16648337)
Pubblicazione: (2025)

Filamin A KO or S2152A KI does not affect KSHV lytic reactivation.
di: Xiaojuan Li (351842)
Pubblicazione: (2025)

Stimulating PV cells at nonsilencing levels does not improve performance of difficult visual discriminations.
di: Lilia Kukovska (22683586)
Pubblicazione: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
di: Xuefeng Liang (3838222)
Pubblicazione: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
di: Xuefeng Liang (3838222)
Pubblicazione: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
di: Xuefeng Liang (3838222)
Pubblicazione: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
di: Xuefeng Liang (3838222)
Pubblicazione: (2025)

Exploration of the Gas Adsorption/Selection Behavior and Its Doping Regulation Strategy of COFs for Improved Gas-Sensing Performance
di: Xuefeng Liang (3838222)
Pubblicazione: (2025)

Cannot write session to /tmp/vufind_sessions/sess_l2aca1p6v1cf0kahugahr2f542